Rebecca Hubbard
Professor, Clinician-Educator
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Rebecca Hubbard is a Professor and Clinician-Educator at the University of Pennsylvania, USA. Her research areas include the epidemiology of liver disease, diabetic retinal disease, and the impacts of chemotherapy shortages on cancer patients. She also focuses on health equity in cancer diagnostics and the evaluation of observational study methodologies.
Articles (20)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Background Annual surveillance mammography is recommended for women with a personal history of breast cancer. Risk prediction models that estimate mammography failures such as interval second breast cancers could help to tailor surveillance imaging regimens to women’s individual risk profiles. Methods In a cohort of women with a history of breast cancer receiving surveillance mammography in the Breast Cancer Surveillance Consortium in 1996-2019, we used Least Absolute Shrinkage and Selection Operator (LASSO)-penalized regression to estimate the probability of an interval second cancer (invasive cancer or ductal carcinoma in situ) in the 1 year after a negative surveillance mammogram. Based on predicted risks from this one-year risk model, we generated cumulative risks of an interval second cancer for the five-year period after each mammogram. Model performance was evaluated using cross-validation in the overall cohort and within race and ethnicity strata. Results In 173 290 surveillance mammograms, we observed 496 interval cancers. One-year risk models were well-calibrated (expected/observed ratio = 1.00) with good accuracy (area under the receiver operating characteristic curve = 0.64). Model performance was similar across race and ethnicity groups. The median five-year cumulative risk was 1.20% (interquartile range 0.93%-1.63%). Median five-year risks were highest in women who were under age 40 or pre- or perimenopausal at diagnosis and those with estrogen receptor-negative primary breast cancers. Conclusions Our risk model identified women at high risk of interval second breast cancers who may benefit from additional surveillance imaging modalities. Risk models should be evaluated to determine if risk-guided supplemental surveillance imaging improves early detection and decreases surveillance failures.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Collaborators (16)
Martin Eklund
Associate professor
Karolinska Institutet
Hari Vigneswaran
Karolinska Institutet
Diana Miglioretti
Professor and Division Chief of Biostatistics
University of California, Davis
Louise Henderson
Professor
University of North Carolina
Lainie Martin
University of Pennsylvania Perelman School of Medicine
Ronac Mamtani
University of Pennsylvania
Janie M Lee
-
Joseph Hogan
Brown University
Jason A. Roy
Rutgers University
Oluwadamilola Fayanju
University of Pennsylvania
Marina Serper
Assistant Professor of Medicine
University of Pennsylvania
Ravi Parikh
Assistant Professor, Clinician-Educator
University of Pennsylvania
Kossi Edoh
Professor
North Carolina A&T State University
Nandita Mitra
Professor, Clinician-Educator
University of Pennsylvania
Christopher Li
Fred Hutchinson Cancer Research Center
Jessie Torgersen
Assistant Professor of Medicine
University of Pennsylvania Perelman School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.